Masimo Co. (NASDAQ:MASI) Shares Sold by Bamco Inc. NY

Bamco Inc. NY lessened its holdings in Masimo Co. (NASDAQ:MASI - Free Report) by 11.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 307,144 shares of the medical equipment provider's stock after selling 40,056 shares during the quarter. Bamco Inc. NY owned approximately 0.57% of Masimo worth $50,771,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Barclays PLC increased its position in Masimo by 152.6% during the 3rd quarter. Barclays PLC now owns 39,957 shares of the medical equipment provider's stock valued at $5,329,000 after purchasing an additional 24,137 shares during the period. Tidal Investments LLC purchased a new stake in shares of Masimo during the third quarter valued at about $319,000. GAMMA Investing LLC boosted its holdings in shares of Masimo by 136.5% in the 4th quarter. GAMMA Investing LLC now owns 466 shares of the medical equipment provider's stock valued at $77,000 after buying an additional 269 shares in the last quarter. Nordea Investment Management AB grew its position in shares of Masimo by 0.7% in the 4th quarter. Nordea Investment Management AB now owns 19,182 shares of the medical equipment provider's stock worth $3,206,000 after buying an additional 142 shares during the last quarter. Finally, Fifth Third Wealth Advisors LLC acquired a new position in shares of Masimo during the fourth quarter worth $241,000. 85.96% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Masimo

In other Masimo news, Director Craig B. Reynolds sold 2,053 shares of the company's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $166.13, for a total transaction of $341,064.89. Following the completion of the transaction, the director now owns 16,581 shares in the company, valued at approximately $2,754,601.53. This represents a 11.02 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Bilal Muhsin sold 30,000 shares of the business's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $167.49, for a total transaction of $5,024,700.00. Following the transaction, the chief operating officer now owns 24,172 shares in the company, valued at approximately $4,048,568.28. This trade represents a 55.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 9.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the company. Raymond James dropped their target price on Masimo from $204.00 to $185.00 and set an "outperform" rating on the stock in a research note on Wednesday. BTIG Research set a $193.00 target price on Masimo and gave the company a "buy" rating in a research report on Wednesday. Wells Fargo & Company cut their target price on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a report on Wednesday. Piper Sandler reaffirmed an "overweight" rating and set a $200.00 price objective (down from $215.00) on shares of Masimo in a report on Wednesday. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a report on Thursday, April 10th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $191.60.

Masimo Trading Up 2.4 %

MASI traded up $3.66 during mid-day trading on Thursday, hitting $153.77. 905,901 shares of the stock were exchanged, compared to its average volume of 658,914. The company has a market cap of $8.31 billion, a PE ratio of 106.05 and a beta of 1.23. The company has a current ratio of 2.01, a quick ratio of 1.11 and a debt-to-equity ratio of 0.50. The firm's fifty day moving average is $162.92 and its two-hundred day moving average is $166.42. Masimo Co. has a 1-year low of $101.61 and a 1-year high of $194.88.

Masimo (NASDAQ:MASI - Get Free Report) last announced its earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.12. The firm had revenue of $372.00 million for the quarter, compared to the consensus estimate of $367.79 million. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm's revenue for the quarter was down 24.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 EPS. Equities analysts forecast that Masimo Co. will post 4.1 earnings per share for the current fiscal year.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.